1 / 63

CASE PRESENTATION

CASE PRESENTATION. Patricia Baile – PL1 December 16, 2009. 16 year old male presents to the ER with chest pain. HPI. Chest pain x 6 days Sharp, stabbing sensation on left side of chest Constant PS 7/10 Worse when lying on left side and on inspiration Radiating to back

amaya-weiss
Download Presentation

CASE PRESENTATION

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. CASE PRESENTATION Patricia Baile – PL1 December 16, 2009

  2. 16 year old male presents to the ER with chest pain

  3. HPI • Chest pain x 6 days • Sharp, stabbing sensation on left side of chest • Constant • PS 7/10 • Worse when lying on left side and on inspiration • Radiating to back • Mild improvement with aspirin and acetaminophen

  4. HPI • Chest pain • Associated with nausea, dizziness and blurring of vision 2 days prior • No diaphoresis • On day of admission, chest pain persistent, no improvement with acetaminophen hence BIB EMS to ER

  5. ROS • Denies recent strenuous physical activity • No fever • No URI symptoms • No sick contacts • No joint pains • No dyspnea

  6. Past Medical History • Asthma • 9 previous hospitalizations, last 1 year prior • No ICU, no intubation • Advair BID • Singulair 10 mg PO QD • Albuterol PRN

  7. Family History • + Asthma • + DM • + Hypertension • + CAD • No sudden death • No CVA • No connective tissue disorders

  8. Birth History • FT, NSVD, no complication • Immunization History • Up to date

  9. Adolescent History • Currently in 9th grade (behind 2 years) • Lives with mother, stepfather and older brother • No sport or after-school activity • Denies drugs, alcohol, tobacco • Sexually active, has had 8 partners, uses condoms, no STD history (never tested)

  10. Physical Examination • BP 102/58 HR 72 RR 18 O2 100%RA T 98.3 • Pain score: 6-7/10 • Wt: 76.9 kg (90%) Ht: 185 cm (90%) • GS: non-toxic appearing • HEENT: NCAT, congested turbinates, TMI, mild erythema OP, no CLAD • C/L: SCE, good air entry b/l, CTAB, no crackles, no rales, no tenderness on palpation of chest • CV: RRR, no m/r/g • Abdomen: soft, ND, NT, no organomegaly • Ext: well-perfused, good distal pulses

  11. EKG

  12. Labs • CBC: 6.9 > 13.7/39.1< 251 N 68 L 20 • BMP: 138/3.8/100/26/7/0.6/104/8.3 • LFT: 3.9/6.9/25/109/0.7/74 • Lipase: 12 • CPK: 1751 • CKMB: 168.8 • Troponin T: 8.77

  13. Labs • Lipid profile • Cholesterol: 106 • TG: 49 • HDL: 31 • LDL: 65 • CRP: 7.5 • Urine Drug Screen: Negative

  14. Labs • RSV/Flu: Negative • Rapid strep test: negative • Throat culture • ASO: 165 • Streptozyme: Positive • Respiratory viral panel: Negative

  15. Ancillary Tests • Chest Radiograph • Normal chest

  16. Ancillary Tests • Initial Echo • Normal LV ejection fraction • Normal RV function • Mild inferolateral akinesis • Inferior wall akinesis • Small pericardial effusion

  17. Initial Impression • 16 year old male with Juvenile pattern pericarditis; Asthma exacerbation

  18. Hospital Course • Admitted to PICU • Cardiac enymes gradually decreased • Repeat Echo done • Cardiac catheterization done

  19. Ancillary Tests • Repeat Echo • Myocarditis with LV inferior/posterior wall motion abnormality: persistent abnormal LV wall motion • Suboptimal LV shortening fraction • Normal diastolic LV function • Trace inferior and posterior pericardial effusion

  20. Ancillary Tests • Cardiac catheterization • Clear vessels • Decreased ejection fraction • Decreased motion of LV

  21. FINAL DIAGNOSIS • 16 year old male with chest pain secondary to Myocarditis; Asthma exacerbation

  22. MYOCARDITIS

  23. Introduction • Clinical syndrome characterized by inflammation of myocytes resulting from infectious, toxic, and autoimmune etiologies. • Ongoing viral infection, myocardial destruction, and adverse remodeling can lead to persistent ventricular dysfunction and dilated cardiomyopathy.

  24. Introduction • Infectious etiologies, particularly viral, are most common in children. • The most common causes of viral myocarditis are enterovirus (coxsackie group B) and adenovirus

  25. Incidence • Incidence of myocarditis in children is unknown • Inflammatory infiltrates and myocardial cell damage were found at autopsy in 3 to 40% of infants and children who died suddenly unrelated to trauma • 17 percent of infants who died of SIDS had histopathologic evidence of myocarditis

  26. Incidence • In one retrospective study from a single tertiary Canadian center, the estimated prevalence of myocarditis presenting to their emergency department was 0.5 cases per 10,000 visits • A review of all the autopsies performed at a single English pediatric tertiary center over a ten-year period (1996 to 2005) identified 28 of 1516 cases with myocarditis (1.8 percent)

  27. Pathophysiology • In susceptible patients: • Viral RNA uptake  cytotoxic necrosis  rapid cell death • More common presentation • 4-14 days post-infection  immune response (macrophage activation and cytokine expression)  natural killer cells target myocardium expressing the viral RNA and continue myocyte necrosis

  28. Pathophysiology • TNF is involved in rapidly clearing virus and signals additional proinflammatory cells, activates endothelial cells, and has direct negative inotropic effects • Cytotoxic T lymphocytes infiltrate myocytes and trigger lysis of these cells

  29. Pathophysiology • In the chronic phases, the effects of either inadequate or inappropriately abundant immune response can lead to the long-term sequelae of dilated cardiomyopathy and heart failure

  30. Pathophysiology • Ongoing study has demonstrated the presence of antimyosin autoantibodies and other immunomodulators long after initial viral infection

  31. Clinical Manifestation • Nonspecific illness • Fatigue • Mild dyspnea • Myalgias • Fever (20%) • Chest pain (35%) • most commonly described as a pleuritic, sharp, stabbing precordial pain • may be substernal and squeezing

  32. Clinical Manifestation • In a 6-year study of pediatric ED patients, the most common presenting symptom was dyspnea and more than half of patients were initially diagnosed with asthma or pneumonia. • May be asymptomatic

  33. Clinical manifestation • Symptoms of heart failure • Dyspnea on exertion • Orthopnea • Shortness of breath • Palpitation

  34. Physical Findings • Tachypnea and retractions • S3 and occasionally S4 gallops may be present and are important signs of impaired ventricular function • If the right or left ventricular dilation is severe, auscultation may reveal murmurs of functional mitral or tricuspid insufficiency

  35. Physical Findings • Signs of low cardiac output • Pericardial friction rub and effusion may become evident in some patients with myopericarditis • A widely inflamed heart shows the classic signs of ventricular dysfunction including the following: • Jugular venous distention • Bibasilar crackles • Ascites • Peripheral edema

  36. Causes • Infectious • Toxic • Immunologic

  37. Infectious Causes • Viral myocarditis is the most common • Parvovirus B19, 36.6% • Enterovirus, 32.6% • Human herpesvirus 6 (HHV-6), 10.5% • Adenovirus, 8.1% • Co-infection with HHV-6 and parvovirus B19, 12.6% • HIV

  38. Infectious Causes • Bacterial causes • Most common worldwide is Diphtheria • Streptococcal and staphylococcal species and Bartonella, Brucella, Leptospira, and Salmonella species can spread to the myocardium as a consequence of severe cases of endocarditis • Chagas disease • Parasitic myocarditis from trypanosomiasis

  39. Toxic Causes • Numerous medications (eg, lithium, doxorubicin, cocaine, numerous catecholamines, acetaminophen) may exert a direct cytotoxic effect on the heart • Zidovudine (AZT) has been associated with myocarditis

  40. Toxic causes • Environmental toxins include lead, arsenic, and carbon monoxide • Wasp and scorpion stings and spider bites, specifically black widows, may cause myocarditis • Radiation therapy

  41. Immunologic Etiology • Connective tissue disorders • Systemic lupus erythematosus (SLE) • Rheumatoid arthritis • Scleroderma • Dermatomyositis • Idiopathic inflammatory and infiltrative disorders such as Kawasaki disease, sarcoidosis, and giant cell arteritis may be a cause

  42. Differential Diagnoses • Acute Coronary Syndrome • Pneumonia • Congestive Heart Failure • Aortic Dissection • Pulmonary Embolism • Esophageal Perforation, Rupture and Tears • Viral syndrome

  43. Diagnostic Studies • EKG • CXR • Cardiac enzymes • Echo • MRI with contrast • Cardiac catheterization • Other tests

  44. EKG • Classical triad • Sinus tachycardia (>100 in a child; >120 in an infant; >150 in a neonate) • Low voltage complexes • ST segment and T wave changes • Other abnormalities like, varying AV blocks, bundle branch blocks, both supraventricular and ventricular arrhythmias and an even an anterior wall myocardial infarction pattern

  45. Chest Radiograph • Typically include cardiomegaly, although heart size may be normal • Pulmonary vascular congestion is often present

  46. Cardiac Enzymes • Elevation reflects myocardial necrosis • Seen in some patients with myocarditis • Experimental and clinical findings in adults suggest that elevations of cardiac troponin I or T (cTnI or cTnT) levels may be more common than CK-MB elevations in patients with biopsy-proven myocarditis

  47. Echocardiography • Enlarged Left Ventricular (LV) dimensions, left atrial enlargement and impaired ejection fraction (EF) and shortening fraction • Normal EF in children is 64+4% • 2D echo reveals a large, hypo contractile LV which is globular, with thin walls, mild pericardial effusion and occasional regional wall motion abnormalities

  48. MRI • Said to pick up earliest abnormality in Myocarditis • Document the location and extent of inflammation • Gadolinium enhancement was greater in patients with myocarditis than in normal controls

  49. Cardiac Catheterization • Reveals depressed cardiac index, elevated left ventricular end diastolic pressure, and elevated mean atrial pressure • Angiography shows decreased left ventricular function with or without mitral regurgitation • Main purpose is to obtain samples by endomyocardial biopsy (EMB) for pathologic and microbiologic analysis

More Related